Physician profile
Joe E Whitaker
NPI 1881613859
$14,039.47
in general payments reported to CMS, 2019-2025
57 companies · $1,845 in 2025
The $1,845 reported for 2025 was more than what 93% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,243 · 2020: $1,819 · 2021: $2,480 · 2022: $2,084 · 2023: $1,783 · 2024: $1,785 · 2025: $1,845.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,414.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,413.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $2,091.28 | 2019-2025 | Breztri, Airsupra, Farxiga |
| Novo Nordisk INC | $1,807.64 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Abbvie INC. | $1,613.75 | 2019-2025 | Rinvoq, Vraylar, Linzess |
| Glaxosmithkline, LLC. | $1,351.08 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Pfizer INC. | $902.54 | 2019-2025 | |
| Amgen INC. | $722.99 | 2019-2025 | Repatha, Otezla, Evenity |
| Lilly USA, LLC | $602.72 | 2019-2025 | Mounjaro, Zepbound, Omvoh |
| Biotronik INC. | $550.38 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $425.66 | 2021-2025 | |
| Janssen Pharmaceuticals, INC | $341.11 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $320.75 | 2019-2023 | |
| Biohaven Pharmaceuticals, INC. | $242.64 | 2020-2021 | |
| Astellas Pharma US INC | $206.64 | 2019-2024 | Veozah |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $204.24 | 2023-2024 | Xifaxan, Ibschek |
| Esperion Therapeutics, INC. | $191.55 | 2020-2025 | Nexletol |
Show all 57 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joe Whitaker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.